REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 142 filers reported holding REVOLUTION MEDICINES INC in Q3 2022. The put-call ratio across all filers is 0.26 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,057,012 | +3.5% | 74,314 | +0.0% | 0.01% | +20.0% |
| Q2 2023 | $1,987,525 | -11.6% | 74,300 | -28.4% | 0.01% | -16.7% |
| Q1 2023 | $2,247,442 | +246.9% | 103,760 | +281.5% | 0.01% | +200.0% |
| Q4 2022 | $647,904 | -76.3% | 27,200 | -80.4% | 0.00% | -77.8% |
| Q3 2022 | $2,730,000 | +157.1% | 138,454 | +154.0% | 0.01% | +125.0% |
| Q2 2022 | $1,062,000 | -70.5% | 54,504 | -61.3% | 0.00% | -63.6% |
| Q1 2022 | $3,594,000 | +12.0% | 140,881 | +10.5% | 0.01% | +57.1% |
| Q4 2021 | $3,208,000 | +2.8% | 127,445 | +12.4% | 0.01% | 0.0% |
| Q3 2021 | $3,121,000 | -19.3% | 113,434 | -6.9% | 0.01% | -22.2% |
| Q2 2021 | $3,866,000 | +310.4% | 121,806 | +493.2% | 0.01% | +350.0% |
| Q1 2021 | $942,000 | – | 20,532 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $151,966,000 | 28.85% |
| Ponoi II Management, LLC | 685,011 | $18,845,000 | 27.92% |
| Ponoi Management, LLC | 685,011 | $18,845,000 | 16.73% |
| Column Group LLC | 3,347,245 | $92,083,000 | 10.48% |
| TRV GP IV, LLC | 1,419,900 | $39,061,000 | 8.86% |
| Cormorant Asset Management, LP | 3,144,700 | $86,511,000 | 3.52% |
| Boxer Capital, LLC | 3,484,264 | $95,852,000 | 3.35% |
| BVF INC/IL | 2,485,049 | $68,364,000 | 2.67% |
| Casdin Capital, LLC | 2,800,000 | $77,028,000 | 1.92% |
| COMMODORE CAPITAL LP | 226,228 | $6,224,000 | 1.64% |